1,25(OH)2D3 Differently Affects Immunomodulatory Activities of Mesenchymal Stem Cells Depending on the Presence of TNF-α, IL-1β and IFN-γ
Open Access
- 14 December 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (12), 2211
- https://doi.org/10.3390/jcm8122211
Abstract
Periodontal ligament-derived mesenchymal stem cells (hPDLSCs) possess immunomodulatory abilities which are strongly enhanced by various inflammatory cytokines. Vitamin D3 has anti-inflammatory effects on hPDLSCs and immune cells. However, no study to date has directly compared the influence of 1,25(OH)2D3 on the immunomodulatory activities of hPDLSCs in the presence of different cytokines. In the present study, the effects of hPDLSCs treated with tumor necrosis factor (TNF)-α, interleukin (IL)-1β, or interferon (IFN)-γ in the presence of 1,25(OH)2D3 on the proliferation of allogenic CD4+ T lymphocyte or on the functional status of primary CD68+ macrophages were analyzed in coculture models. Additionally, the effects of 1,25(OH)2D3 on TNF-α-, IL-1β-, and IFN-γ-induced gene expression of some immunomodulatory factors in hPDLSCs were compared. Under coculture conditions, 1,25(OH)2D3 increased or decreased CD4+ T lymphocyte proliferation via hPDLSCs, depending on the cytokine. hPDLSCs primed with 1,25(OH)2D3 and different cytokines affected pro- and anti-inflammatory cytokine expression in macrophages variably, depending on the priming cytokine. With one exception, 1,25(OH)2D3 significantly reduced TNF-α-, IL-1β-, and IFN-γ-induced expression of all the investigated immunomediators in hPDLSCs, albeit to different extents. These results suggest that 1,25(OH)2D3 influences the immunomodulatory activities of hPDLSCs depending qualitatively and quantitatively on the presence of certain inflammatory cytokines.Keywords
Funding Information
- Austrian Science Fund (P29440)
This publication has 49 references indexed in Scilit:
- Activity of 25-Hydroxylase in Human Gingival Fibroblasts and Periodontal Ligament CellsPLOS ONE, 2012
- Mesenchymal stromal cell ‘licensing’: a multistep processLeukemia, 2011
- Immunosuppressive properties of human umbilical cord‐derived mesenchymal stem cells: role of B7‐H1 and IDOImmunology & Cell Biology, 2010
- Significance of elevated gingival crevicular fluid tumor necrosis factor-α and interleukin-8 levels in chronic hemodialysis patients with periodontal diseaseJournal of Periodontal Research, 2010
- Elevated Plasma Calcifediol Is Associated With Aggressive PeriodontitisThe Journal of Periodontology, 2009
- Levels of Interferon‐Gamma and Transcription Factor T‐Bet in Progressive Periodontal Lesions in Patients With Chronic PeriodontitisThe Journal of Periodontology, 2009
- Indoleamine 2,3‐Dioxygenase Expression and Regulation in Chronic PeriodontitisThe Journal of Periodontology, 2009
- Vitamin D Signaling, Infectious Diseases, and Regulation of Innate ImmunityInfection and Immunity, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The periodontal ligament: a unique, multifunctional connective tissuePeriodontology 2000, 1997